2011
DOI: 10.1037/a0025668
|View full text |Cite
|
Sign up to set email alerts
|

Increasing ethnic minority participation in substance abuse clinical trials: Lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.

Abstract: Underrepresentation in clinical trials limits the extent to which ethnic minorities benefit from advances in substance abuse treatment. The objective of this article is to share the knowledge gained within the Clinical Trials Network (CTN) of the National Institute on Drug Abuse and other research on recruiting and retaining ethnic minorities into substance abuse clinical trials. The article includes a discussion of two broad areas for improving inclusion— community involvement and cultural adaptation. CTN cas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
49
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(49 citation statements)
references
References 89 publications
(137 reference statements)
0
49
0
Order By: Relevance
“…There appears to be a trend for adapting evidence-based treatments (EBTs) to include elements of AI/AN healing practices and ways of life such as cultural identity, spirituality and religiosity, discrimination, collectivism (33,42,43), and historical trauma (44). Researchers maintain that these inclusions increase the appeal and efficacy of treatment, contribute to better outcomes and engagement among a wider range of AI/ANs (e.g., varying levels of acculturation) and may thereby help to reduce substance-related health disparities (42)(43)(44)(45)(46).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…There appears to be a trend for adapting evidence-based treatments (EBTs) to include elements of AI/AN healing practices and ways of life such as cultural identity, spirituality and religiosity, discrimination, collectivism (33,42,43), and historical trauma (44). Researchers maintain that these inclusions increase the appeal and efficacy of treatment, contribute to better outcomes and engagement among a wider range of AI/ANs (e.g., varying levels of acculturation) and may thereby help to reduce substance-related health disparities (42)(43)(44)(45)(46).…”
Section: Discussionmentioning
confidence: 99%
“…Retention of ethnic minority participants is difficult for medication trials, and recruitment is difficult in part due to strict eligibility criteria. Future studies should consider protocol adaptations to facilitate participant engagement and retention, including community outreach and SUBSTANCE ABUSE TREATMENT involvement, respondent-driven sampling, and enhanced participant incentives (45).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Minority Interest Group of the CTN recently published a review of effective strategies for increasing either recruitment or retention within CTN studies and in the broader literature (Burlew et al, 2011). Along with community involvement, our review showed that the cultural adaptation of the recruitment process increased the inclusion of ethnic minorities in clinical research.…”
Section: Challenges To Cultural Adaptationmentioning
confidence: 99%
“…Participants must be made aware of clinical trials available to them and be informed of the potential benefits and risks to participation. Studies have shown that inclusion of ethnically and diverse populations into clinical trials is a challenge for researchers (Buchanan et al, 2010; Burlew et al, 2012; Dancy et al 2004; Durant, Davis, St. George, Williams, & Blumental, 2007). Because little information is available regarding clinical trial participation among populations under community supervision, strategies to increase their knowledge, effective recruitment, and access to clinical trials are needed.…”
Section: Discussionmentioning
confidence: 99%